Cargando…
P53-regulated autophagy and its impact on drug resistance and cell fate
Wild-type p53 is a stress-responsive transcription factor and a potent tumor suppressor. P53 inhibits the growth of incipient cancer cells by blocking their proliferation or inducing their death through apoptosis. Autophagy is a self-eating process that plays a key role in response to stress. During...
Autores principales: | Shim, Daeun, Duan, Lei, Maki, Carl G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8443158/ https://www.ncbi.nlm.nih.gov/pubmed/34532654 http://dx.doi.org/10.20517/cdr.2020.85 |
Ejemplares similares
-
Erratum: P53-regulated autophagy and its impact on drug resistance and cell fate
por: Shim, Daeun, et al.
Publicado: (2021) -
p53-regulated autophagy is controlled by glycolysis and determines cell fate
por: Duan, Lei, et al.
Publicado: (2015) -
Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells
por: Duan, Lei, et al.
Publicado: (2021) -
Corrigendum to ‘Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells’
por: Duan, Lei, et al.
Publicado: (2022) -
CSE1L is a negative regulator of the RB-DREAM pathway in p53 wild-type NSCLC and can be targeted using an HDAC1/2 inhibitor
por: Duan, Lei, et al.
Publicado: (2023)